The Quest for Affordable Monoclonal Antibodies and Targeted Therapy in Lung Cancer

Costs of anticancer drugs are generally and rightly labeled expensive. Many nations across the globe have limited resources and could hardly afford the basic necessary medications. The United States (US) government in 2022 allocated17.3% of the gross domestic product (GDP) on health care. A $28,176.6 trillion dollars was spent in 2024 on health care, with a significant portion covering drug costs. Insulin price was reduced to $35 with plans to limit other medications costs.